Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
B&NE Shows Improvement in Its Second Quarter publishersweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publishersweekly.com Daily Mail and Mail on Sunday newspapers.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Thursday. The Dow traded up 0.28% to 36,155 while the NASDAQ rose 1.41% to 14,346.47. The S&P 500 also rose, gaining, 0.86% to 4,588.61.
Equities Research Analysts’ updated eps estimates for Thursday, December 7th: AcelRx Pharmaceuticals (NASDAQ:ACRX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $5.00 target price on the stock. C3.ai (NYSE:AI) had its hold rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $27.00 […]